Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Neofost Injection
Manufacturer/Marketed By : NEON LABORATORIES LTD
$0.83 $0.66
Neofost injection contains an active component as Fosphenytoin. It is a medication that is used in the treatment of epilepsy and certain seizure disorders. It is a water-soluble prodrug of...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
FOSPHENYTOIN
Active Pharmaceutical Ingredient
Neofost Injection
0,83$
0,66$
Neofost injection contains an active component as Fosphenytoin. It is a medication that is used in the treatment of epilepsy and certain seizure disorders. It is a water-soluble prodrug of phenytoin, which is converted into phenytoin once inside the body. It can control and prevent generalized tonic-clonic seizures, complex partial (psychomotor or temporal lobe) seizures, status epilepticus, and seizures during neurosurgery. Generalized tonic-clonic seizures are the seizures with loss of consciousness, muscle rigidity, and convulsions affecting the entire brain. Complex partial (psychomotor or temporal lobe) seizures involve altered consciousness and unusual behaviors originating from a specific brain area. Status epilepticus is the prolonged or repeated seizures without recovery, requiring immediate medical intervention. Individuals who are hypersensitive or allergic to Neofost injection or phenytoin should not use this medication. Hypersensitivity reactions can manifest as skin rashes, itching, swelling, fever, or more severe allergic reactions. This medication is contraindicated in individuals with hypersensitivity to the drug or phenytoin, sinus bradycardia, SA block, second third-degree AV block, Adams-Stokes syndrome, porphyria, concurrent use with delavirdine, use during and after coronary artery bypass grafting (CABG) surgery, and intramuscular use with delavirdine or droperidol, due to potential risks and interactions associated with these conditions. Neofost injection is recommended for use in both children and older adults, but with careful consideration of individualized dosing, monitoring, and potential risks. Dosage adjustments and close medical supervision are important to ensure safe and effective treatment in these age groups.
Active Pharmaceutical Ingredient
Uses
• Seizure control
• Status epilepticus
• Seizure prevention during surgery
• Alternative to oral phenytoin
• Emergency seizure management
Benefits
Neofost injection involves its conversion to the active drug phenytoin in the body. Phenytoin, a widely used anticonvulsant, works by stabilizing neuronal membranes and inhibiting excessive firing of neurons, thereby reducing abnormal electrical activity in the brain that can lead to seizures. This is achieved through multiple mechanisms, including modulation of sodium channels, which are crucial in generating and propagating nerve impulses. By influencing sodium channel kinetics and limiting their excitability, this medication and its active form, phenytoin, help prevent the uncontrolled neuronal firing characteristic of seizures.
Side Effects
Neofost injection causes some side effects like all medications, although not everyone will experience them.
Most Common Side Effects
• Nausea and Vomiting
• Dizziness
• Drowsiness
• Gum Hypertrophy
• Injection Site Reactions
• Blurred Vision
Common Side Effects
• Allergic reactions
• Cardiac effects
• Hypotension
• Hepatic effects
• Blood disorders
• CNS effects
How To Use
Neofost injection is primarily administered intravenously (IV) or, in certain cases, intramuscularly (IM). Intravenous administration involves slowly infusing the medication into a vein, while intramuscular administration entails injecting it into a muscle. The route choice depends on factors such as the patient's condition, urgency of treatment, and accessibility of veins. Intravenous administration allows for rapid delivery, making it suitable for emergencies, while intramuscular administration provides an alternative when intravenous access is difficult. Proper technique and medical supervision are crucial for safe and effective administration, regardless of the chosen route.
Safety Advice
• Breast Feeding: Neofost injection can be excreted in breast milk. Consult your healthcare provider before starting this medication.
• Alcohol: It is generally advisable to limit alcohol consumption or avoid it altogether while taking Neofost injection. Alcohol can increase the risk of side effects and potentially reduce the effectiveness of the medication.
• Liver: Neofost injection is metabolized by the liver, so individuals with liver disease should consult a healthcare provider, especially those with liver conditions.
• Lungs: Patients with pre-existing lung conditions should consult the healthcare provider before starting Neofost injection.
• Driving: Neofost injection can cause dizziness, drowsiness, and blurred vision. Patients should exercise caution when performing activities that require mental alertness, such as driving or operating machinery.
• Pregnancy: Neofost injection can affect the developing fetus. Always consult your healthcare provider before starting this medication.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.